Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Atopic Dermatitis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Novartis Investigative Site, Birmingham, Alabama, United States

  • Novartis Investigative Site, Birmingham, Alabama, United States

  • Novartis Investigative Site, Fort Smith, Arkansas, United States

  • Novartis Investigative Site, Fountain Valley, California, United States

  • Novartis Investigative Site, Los Angeles, California, United States

  • Novartis Investigative Site, Sacramento, California, United States

  • Novartis Investigative Site, Santa Ana, California, United States

  • Novartis Investigative Site, Santa Monica, California, United States

  • Novartis Investigative Site, Washington D.C., District of Columbia, United States

  • Novartis Investigative Site, Miami, Florida, United States

  • Novartis Investigative Site, Atlanta, Georgia, United States

  • Novartis Investigative Site, Macon, Georgia, United States

  • Novartis Investigative Site, Louisville, Kentucky, United States

  • Novartis Investigative Site, Brighton, Massachusetts, United States

  • Novartis Investigative Site, Troy, Michigan, United States

  • Novartis Investigative Site, Saint Joseph, Missouri, United States

  • Novartis Investigative Site, Brooklyn, New York, United States

  • Novartis Investigative Site, Arlington, Texas, United States

  • Novartis Investigative Site, Cypress, Texas, United States

  • Novartis Investigative Site, Dallas, Texas, United States

  • Novartis Investigative Site, Houston, Texas, United States

  • Novartis Investigative Site, San Antonio, Texas, United States

  • Novartis Investigative Site, Caba, Buenos Aires, Argentina

  • Novartis Investigative Site, Caba, Buenos Aires, Argentina

  • Novartis Investigative Site, Rosario, Santa Fe Province, Argentina

  • Novartis Investigative Site, Edmonton, Alberta, Canada

  • Novartis Investigative Site, Hamilton, Ontario, Canada

  • Novartis Investigative Site, Markham, Ontario, Canada

  • Novartis Investigative Site, Montreal, Quebec, Canada

  • Novartis Investigative Site, Verdun, Quebec, Canada

  • Novartis Investigative Site, Guangzhou, Guangdong, China

  • Novartis Investigative Site, Shantou, Guangdong, China

  • Novartis Investigative Site, Changsha, Hunan, China

  • Novartis Investigative Site, Changchun, Jilin, China

  • Novartis Investigative Site, Hangzhou, Zhejiang, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Shanghai, China

  • Novartis Investigative Site, Plzen Bory, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Brest, France

  • Novartis Investigative Site, Lille, France

  • Novartis Investigative Site, Lorient, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Pierre-Bénite, France

  • Novartis Investigative Site, Reims, France

  • Novartis Investigative Site, Rouen, France

  • Novartis Investigative Site, Frankfurt am Main, Hesse, Germany

  • Novartis Investigative Site, Mainz, Rhineland-Palatinate, Germany

  • Novartis Investigative Site, Bad Bentheim, Germany

  • Novartis Investigative Site, Dresden, Germany

  • Novartis Investigative Site, Hamburg, Germany

  • Novartis Investigative Site, Heidelberg, Germany

  • Novartis Investigative Site, Magdeburg, Germany

  • Novartis Investigative Site, Münster, Germany

  • Novartis Investigative Site, Oldenburg, Germany

  • Novartis Investigative Site, Pécs, Baranya, Hungary

  • Novartis Investigative Site, Debrecen, Hajdu Bihar Megye, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Szeged, Hungary

  • Novartis Investigative Site, Ancona, AN, Italy

  • Novartis Investigative Site, Cona, FE, Italy

  • Novartis Investigative Site, Nagoya, Aichi-ken, Japan

  • Novartis Investigative Site, Matsudo, Chiba, Japan

  • Novartis Investigative Site, Kawasaki, Kanagawa, Japan

  • Novartis Investigative Site, Yokohama, Kanagawa, Japan

  • Novartis Investigative Site, Habikino, Osaka, Japan

  • Novartis Investigative Site, Shinagawa Ku, Tokyo, Japan

  • Novartis Investigative Site, Fukuoka, Japan

  • Novartis Investigative Site, Kyoto, Japan

  • Novartis Investigative Site, Rotterdam, South Holland, Netherlands

  • Novartis Investigative Site, Utrecht, Netherlands

  • Novartis Investigative Site, Warsaw, Masovian Voivodeship, Poland

  • Novartis Investigative Site, Katowice, Poland

  • Novartis Investigative Site, Lodz, Poland

  • Novartis Investigative Site, Lublin, Poland

  • Novartis Investigative Site, Warsaw, Poland

  • Novartis Investigative Site, Bardejov, Slovakia

  • Novartis Investigative Site, Komárno, Slovakia

  • Novartis Investigative Site, Košice, Slovakia

  • Novartis Investigative Site, Košice, Slovakia

  • Novartis Investigative Site, Prešov, Slovakia

  • Novartis Investigative Site, Ansan, Gyeonggi-do, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Badalona, Barcelona, Spain

  • Novartis Investigative Site, Alicante, Spain

  • Novartis Investigative Site, Granada, Spain

  • Novartis Investigative Site, Las Palmas GC, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Pontevedra, Spain

  • Novartis Investigative Site, Kaohsiung City, Taiwan

  • Novartis Investigative Site, Taipei, Taiwan

  • Novartis Investigative Site, Taipei, Taiwan

  • Novartis Investigative Site, Dudley, West Midlands, United Kingdom

  • Novartis Investigative Site, Liverpool, United Kingdom